Cargando…
Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member
BACKGROUND: The Family Reported Outcome Measure (FROM-16) assesses the impact of a patient’s chronic illness on the quality of life (QoL) of the patient’s partner or family members. The aim of the study was to translate, explore the structure of and validate the FROM-16. METHODS: The questionnaire w...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992821/ https://www.ncbi.nlm.nih.gov/pubmed/33761949 http://dx.doi.org/10.1186/s12955-021-01738-4 |
_version_ | 1783669458771902464 |
---|---|
author | Elsner, Susanne A. Salek, Sam S. Finlay, Andrew Y. Hagemeier, Anna Bottomley, Catherine J. Katalinic, Alexander Waldmann, Annika |
author_facet | Elsner, Susanne A. Salek, Sam S. Finlay, Andrew Y. Hagemeier, Anna Bottomley, Catherine J. Katalinic, Alexander Waldmann, Annika |
author_sort | Elsner, Susanne A. |
collection | PubMed |
description | BACKGROUND: The Family Reported Outcome Measure (FROM-16) assesses the impact of a patient’s chronic illness on the quality of life (QoL) of the patient’s partner or family members. The aim of the study was to translate, explore the structure of and validate the FROM-16. METHODS: The questionnaire was translated from English into German (forward, backward, four independent translators). Six interviews with family members were conducted to confirm the questionnaire for linguistic, conceptual, semantic and experiential equivalence and its practicability. The final German translation was tested for internal consistency, reproducibility and test validity. Criterion validity was tested by correlating the scores of the FROM-16 and the Global Health Scale (GHS). Principal component analysis, factor analysis, and confirmatory factor analysis was used to assess the questionnaire’s structure and its domains. Reliability and reproducibility were tested computing the intraclass correlation coefficient (ICC) using one sample t-test for testing the hypothesis that the difference between the scores was not different from zero. RESULTS: Overall, 83 family members (61% female, median age: 61 years) completed the questionnaire at two different times (mean interval: 22 days). Internal consistency was good for the FROM-16 scores (Cronbach’s α for total score = 0.86). In those with stable GHS, the ICC for the total score was 0.87 and the difference was not different from zero (p = 0.262) indicating reproducible results. A bi-factor model with a general factor including all items, and two sub-factors comprising the items from the original 2-factor construct had the best fit. CONCLUSIONS: The German FROM-16 has good reliability, test validity and practicability. It can be considered as an appropriate and generic tool to measure QoL of a patient’s partner or family member. Due to the presence of several cross-loadings we do not recommend the reporting of the scores of the two domains proposed for the original version of FROM-16 when using the German version. Thus, in reporting the results emphasis should be put on the total score. Trial registration: Retrospectively registered: DRKS00021070. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-021-01738-4. |
format | Online Article Text |
id | pubmed-7992821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79928212021-03-25 Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member Elsner, Susanne A. Salek, Sam S. Finlay, Andrew Y. Hagemeier, Anna Bottomley, Catherine J. Katalinic, Alexander Waldmann, Annika Health Qual Life Outcomes Research BACKGROUND: The Family Reported Outcome Measure (FROM-16) assesses the impact of a patient’s chronic illness on the quality of life (QoL) of the patient’s partner or family members. The aim of the study was to translate, explore the structure of and validate the FROM-16. METHODS: The questionnaire was translated from English into German (forward, backward, four independent translators). Six interviews with family members were conducted to confirm the questionnaire for linguistic, conceptual, semantic and experiential equivalence and its practicability. The final German translation was tested for internal consistency, reproducibility and test validity. Criterion validity was tested by correlating the scores of the FROM-16 and the Global Health Scale (GHS). Principal component analysis, factor analysis, and confirmatory factor analysis was used to assess the questionnaire’s structure and its domains. Reliability and reproducibility were tested computing the intraclass correlation coefficient (ICC) using one sample t-test for testing the hypothesis that the difference between the scores was not different from zero. RESULTS: Overall, 83 family members (61% female, median age: 61 years) completed the questionnaire at two different times (mean interval: 22 days). Internal consistency was good for the FROM-16 scores (Cronbach’s α for total score = 0.86). In those with stable GHS, the ICC for the total score was 0.87 and the difference was not different from zero (p = 0.262) indicating reproducible results. A bi-factor model with a general factor including all items, and two sub-factors comprising the items from the original 2-factor construct had the best fit. CONCLUSIONS: The German FROM-16 has good reliability, test validity and practicability. It can be considered as an appropriate and generic tool to measure QoL of a patient’s partner or family member. Due to the presence of several cross-loadings we do not recommend the reporting of the scores of the two domains proposed for the original version of FROM-16 when using the German version. Thus, in reporting the results emphasis should be put on the total score. Trial registration: Retrospectively registered: DRKS00021070. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-021-01738-4. BioMed Central 2021-03-24 /pmc/articles/PMC7992821/ /pubmed/33761949 http://dx.doi.org/10.1186/s12955-021-01738-4 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Elsner, Susanne A. Salek, Sam S. Finlay, Andrew Y. Hagemeier, Anna Bottomley, Catherine J. Katalinic, Alexander Waldmann, Annika Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member |
title | Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member |
title_full | Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member |
title_fullStr | Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member |
title_full_unstemmed | Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member |
title_short | Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member |
title_sort | validation of the german version of the family reported outcome measure (from-16) to assess the impact of disease on the partner or family member |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992821/ https://www.ncbi.nlm.nih.gov/pubmed/33761949 http://dx.doi.org/10.1186/s12955-021-01738-4 |
work_keys_str_mv | AT elsnersusannea validationofthegermanversionofthefamilyreportedoutcomemeasurefrom16toassesstheimpactofdiseaseonthepartnerorfamilymember AT saleksams validationofthegermanversionofthefamilyreportedoutcomemeasurefrom16toassesstheimpactofdiseaseonthepartnerorfamilymember AT finlayandrewy validationofthegermanversionofthefamilyreportedoutcomemeasurefrom16toassesstheimpactofdiseaseonthepartnerorfamilymember AT hagemeieranna validationofthegermanversionofthefamilyreportedoutcomemeasurefrom16toassesstheimpactofdiseaseonthepartnerorfamilymember AT bottomleycatherinej validationofthegermanversionofthefamilyreportedoutcomemeasurefrom16toassesstheimpactofdiseaseonthepartnerorfamilymember AT katalinicalexander validationofthegermanversionofthefamilyreportedoutcomemeasurefrom16toassesstheimpactofdiseaseonthepartnerorfamilymember AT waldmannannika validationofthegermanversionofthefamilyreportedoutcomemeasurefrom16toassesstheimpactofdiseaseonthepartnerorfamilymember |